Epidemiology of purulent bacterial meningitis in the period of pneumococcal and haemophilus vaccination in the Russian Federation


Koroleva I.S., Koroleva M.A., Melnikova A.A.

1Central Research Institute of Epidemiology, Russian Federal Service for Supervision of Consumer Rights Protection and Human Well-Being, Moscow, Russia; 2Russian Federal Service for Supervision of Consumer Rights Protection and Human Well-Being, Moscow, Russia
Objective. To determine the current epidemiological features of the generalized form of meningococcal infection, pneumococcal meningitis, and Haemophilus meningitis during routine Haemophilus and pneumococcal vaccination and meningococcal vaccination, as epidemically indicated.
Materials and methods. 170 reporting forms from 85 regions of the Russian Federation, which describe 2219 cases of purulent bacterial meningitis, were analyzed. Biomaterials from 370 patients were examined.
Results. There was a vaccination-induced decrease in the incidence rates of pneumococcal and Haemophilus meningitis in children under 5 years of age.
Conclusion. It is necessary to increase pneumococcal vaccination coverage in children and adults older than 60 years; to expand indications for vaccination against Haemophilus influenza, so that the vaccinated should include all children above 3 months of age, and not just risk-group children; to consider prospects for the national immunization calendar to include vaccination against meningococcal infection, by taking into account its heavy burden and poor prognosis due to that there may be a regular epidemic rise in morbidity rates.
Keywords: purulent bacterial meningitis, epidemiological monitoring, vaccination
Read entire article

Literature

  1. Skripchenko N.V., Vilnic А.А. (eds.). [Meningococcal infection in children. Guide for doctors]. Saint-Petersburg: Taktik-Studio 2015: 840 р. (In Russ.).
  2. Swartz M.N. Bacterial meningitis – a view of the past 90 year. N. Engl. J. Med. 2012; 351(18): 1826–8.
  3. Bottomley M.J., Serruto D., Safadi M.A.P. et al. Future challenges in the elimination of bacterial meningitis. Vaccine 2012; (Suppl. 2): B78–86.
  4. Dery M.A.. Changing epidemiology of bacterial meningitis. Curr Infect. Dis. Rep. 2007; (9): 301–7.
  5. Wenger J.D., Hightower A.W., Facklam R.R., et al. Bacterial meningitis in the United States, 1986: report of a multistate surveillance study. The Bacterial Meningitis Study Group. J. Infect. Dis. 1990; 162: 1316–23.
  6. Schuchat A., Robinson K., Wenger J.D. et al. Bacterial meningitis in the United States in 1995. Active Surveillance Team. N. Engl. J. Med. 1997; 337: 970–6.
  7. Tan L.K., Carlone G.M., Borrow R. Advances in the development of vaccines against Neisseria meningitidis. N. Engl. J. Med. 2010; 362(16): 1511–20.
  8. Koroleva I.S., Koroleva M.A., Beloshitskiy G.V. [The current epidemic situation for meningococcal infection in the Russian Federation and the possibility of vaccine prevention]. Meditsinskiy alfavit. Epidemiologiya i gigiyena 2016; (1): 15–7. (In Russ.).


About the Autors

For correspondence:
Irina S. Koroleva, MD, Head, Laboratory for Epidemiology of Meningococcal Infection and Purulent Bacterial Meningitis, Central Research Institute of Epidemiology, Russian Federal Service for Supervision of Consumer Rights Protection and Human Well-Being
Address: 3a, Novogireevskaya St., Moscow 111123, Russia
Теlephone: +7(495) 672-11-28
E-mail: irina-korol@yandex.ru
Information about the authors:
Maria А. Koroleva, Cand. Med. Sci., Senior Researcher, Laboratory for Epidemiology of Meningococcal Infection and Purulent Bacterial Meningitis, Central Research Institute of Epidemiology, Russian Federal Service for Supervision of Consumer Rights Protection and Human Well-Being, Moscow, Russia; e-mail: korolevamaria389@mail.ru
Albina А. Melnikova – Cand. Med. Sci., Deputy Head, Department of Epidemiological Surveillance, Federal Service for Supervision of Consumer Rights Protection and Human Well-Being, Moscow, Russia; e-mail: Melnikova_AA@gsen.ru


Similar Articles

Back to Content

Бионика Медиа